A Systematic Review on the Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in Gastrointestinal Motility Disorders: More Control, Less Risk

Gastrointestinal motility disorders have been thought to occur due to an imbalance in the interaction of the gut-brain axis, which is regulated by serotonin. This recent discovery can be exploited to find newer therapeutic agents such as selective serotonin reuptake inhibitors for functional gastroi...

Descripción completa

Detalles Bibliográficos
Autores principales: Acharekar, Maitri V, Guerrero Saldivia, Sara E, Unnikrishnan, Sumedha, Chavarria, Yeny Y, Akindele, Adebisi O, Jalkh, Ana P, Eastmond, Aziza K, Shetty, Chaitra, Rizvi, Syed Muhammad Hannan A, Sharaf, Joudi, Williams, Kerry-Ann D, Tariq, Maha, Balani, Prachi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440984/
https://www.ncbi.nlm.nih.gov/pubmed/36081982
http://dx.doi.org/10.7759/cureus.27691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440984/
https://www.ncbi.nlm.nih.gov/pubmed/36081982
http://dx.doi.org/10.7759/cureus.27691

Ejemplares similares